Teva Branded Pharmaceutical Products R&d Llc

This study aimed to check the long-term safety and effectiveness of a monthly injection called fremanezumab for preventing migraines in children and teenagers aged 6 to 17. It involved 506 young participants who had already been in related studies, tracking them for up to 7 years…

This study tested a long-acting, injectable version of the medication olanzapine (called TV-44749) for adults with schizophrenia. The goal was to see if a monthly injection could effectively control symptoms and was safe to use for up to a year. Researchers compared the injection…

This study tested a new long-acting injectable form of the schizophrenia medication olanzapine against the standard oral pill. It involved 153 adults with stable schizophrenia to see how the body absorbs the medicine from each form and to check the safety of the injection. The go…

This study aimed to see how the body absorbs new versions of an experimental drug called TEV-56286 compared to an original version. It involved 47 healthy adult participants who each tried different drug formulas in a specific order. The main goal was to measure drug levels in th…

This study aimed to understand how three new long-acting injection formulas of the drug olanzapine are absorbed by the body. It involved 106 adults with schizophrenia or schizoaffective disorder. Researchers compared how long the drug stayed in the bloodstream and monitored for s…